BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Market News

Allscripts (NASDAQ: MDRX): Q3 2019 Earnings Snapshot

— Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss of $0.03 per share. The results came in line with the analysts’ expectations. — Revenue increased by 3% to $444 million and adjusted revenue rose by 1% to $445 million. This is compared to the […]

$MDRX November 4, 2019 1 min read

— Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss of $0.03 per share. The results came in line with the analysts’ expectations.

— Revenue increased by 3% to $444 million and adjusted revenue rose by 1% to $445 million. This is compared to the consensus estimates of $450.16 million.

Earnings Update by AlphaStreet

— Bookings jumped by 19% to $236 million in the third quarter of 2019. Contract revenue backlog totaled $3.9 billion as of September 30, 2019.

— Looking ahead, the company expects revenue growth to improve as it benefits from the strategic investments across both its Provider and Veradigm businesses.

ADVERTISEMENT

— For the full year 2019, the company narrowed its adjusted earnings guidance to the range of $0.67 to $0.70 per share from the previous range of $0.65 to $0.70 per share. The street’s view is $0.68 per share.

— Bookings are still anticipated to be in the range of $1.05 billion to $1.10 billion for the full year.

— Adjusted revenue outlook is reiterated in the range of $460 million to $470 million for the fourth quarter of 2019 versus the consensus estimates of $462.74 million.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

ADVERTISEMENT